R&D Changing Faces: Boards of Directors and Advisory Boards – Ap... Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.
Digital Changing Faces: Digital and supplier hires – April 2026 Leadership changes across digital health, diagnostics, clinical trial technology, and life sciences suppliers continued in April.
R&D Changing Faces: Pharma and biotech, April 2026 April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.
R&D Changing Faces: Board of Directors and Advisory Boards, Marc... Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, March 202... March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.
Digital Changing Faces: Digital and supplier, March 2026 Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.